Membership
Tour
Register
Log in
CANCER THERAPEUTICS LABORATORIES, INC.
Follow
Organization
LOS ANGELES, CA, US
Organizations
Overview
Industries
People
People
Information
Transactions
Events
Impact
Please log in for detailed analytics
Patents Grants
last 30 patents
Information
Patent Grant
Humanized anti-nuclear antibodies for targeting necrosis in cancer...
Patent number
11,384,157
Issue date
Jul 12, 2022
CANCER THERAPEUTICS LABORATORIES, INC.
Alan Epstein
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Please log in for detailed analytics
Patents Applications
last 30 patents
Information
Patent Application
HUMANIZED ANTI-NUCLEAR ANTIBODIES FOR TARGETING NECROSIS IN CANCER...
Publication number
20230027730
Publication date
Jan 26, 2023
Cancer Therapeutics Laboratories, Inc.
Alan EPSTEIN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
HUMANIZED ANTI-NUCLEAR ANTIBODIES FOR TARGETING NECROSIS IN CANCER...
Publication number
20200157246
Publication date
May 21, 2020
Cancer Therapeutics Laboratories, Inc.
Alan EPSTEIN
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
TUMOR NECROSIS TARGETING COMPOSITIONS AND METHODS
Publication number
20200147230
Publication date
May 14, 2020
Cancer Therapeutics Laboratories, Inc.
Alan EPSTEIN
C07 - ORGANIC CHEMISTRY
NIH Research Project
last 12 months
processing...
Count: 4
Research Projects
Information
Research Project
Monoclonal Antibodies Against T-Regulatory Cells
Application id
6929723
Award notice date
Jul 11, 2005
Information
Research Project
Monoclonal Antibodies Against T-Regulatory Cells
Application id
6829079
Award notice date
Jul 29, 2004
Information
Research Project
OTHER FUNCTIONS SBIR PHASE II TOPIC 275, GENERIC ERBITUX FOR TREATM...
Application id
8555069
Information
Research Project
TAS::75 0849::TAS THE MAIN TECHNICAL OBJECTIVE OF THIS CONTRACT IS...
Application id
8164744